Prevention of recrudescent toxoplasmic encephalitis using ponazuril in an immunodeficient mouse model.
Mitchell
Sheila M
SM
Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia 24061-0342, USA.
Zajac
Anne M
AM
Kennedy
Tom
T
Davis
Wendell
W
Dubey
J P
JP
Lindsay
David S
DS
D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001921:Brain / Q000469:parasitology; D004195:Disease Models, Animal; D005260:Female; D016867:Immunocompromised Host; D007150:Immunohistochemistry; D008099:Liver / Q000469:parasitology; D008168:Lung / Q000469:parasitology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D055502:Secondary Prevention; D016781:Toxoplasmosis, Cerebral / Q000188:drug therapy* / Q000469:parasitology / Q000517:prevention & control*; D014227:Triazines / Q000008:administration & dosage / Q000494:pharmacology*
D000981:Antiprotozoal Agents; D014227:Triazines; C415002:ponazuril